5 Things to Know Before Your First GLP-1 Conversation
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link

Walking into your first conversation about a GLP-1 medication will go a lot smoother if you understand a few basics first: who these medications are actually approved for, the difference between the two main ingredients, what dose escalation looks like, what "food noise" means, and how compounded products fit into the picture.
Who This Helps
You are probably reading this if you have heard about GLP-1 medications from a friend, a podcast, your social feeds, or a magazine, and you are starting to wonder if they might be right for you. You have not had the conversation with a doctor yet. You may not even know whether you qualify or what to ask.
This article walks through five things worth understanding before that conversation, in plain language, so you can show up informed and use your time with a clinician on the parts that actually need a clinician. Nothing here replaces medical advice. The goal is to make the appointment feel less like a quiz you did not study for.
1. Whether You Might Qualify
The FDA-approved GLP-1 weight loss medications, Wegovy and Zepbound, are approved for adults with a body mass index of 30 or higher, or a BMI of 27 to 29.9 along with at least one weight-related health condition like high blood pressure, type 2 diabetes, or high cholesterol (Wegovy Prescribing Information). Wegovy was also approved in 2024 to reduce cardiovascular event risk in adults who already have cardiovascular disease and are overweight or obese.
For type 2 diabetes, the picture is different. Ozempic and Mounjaro are approved to help adults manage blood sugar, and Ozempic also has approvals for reducing cardiovascular risk in adults with type 2 diabetes and heart disease, and for slowing kidney function decline in certain patients (Ozempic Prescribing Information).
The clinician you talk with will look at your BMI, your weight history, your other health conditions, your family history, and what you have already tried. BMI is a starting point, not the whole picture. Bring your weight, height, and a list of medications you take to your appointment so this part can move quickly.
2. The Two Main Ingredients
Most of the GLP-1 weight loss conversation in 2026 is about two ingredients: semaglutide and tirzepatide.
Semaglutide is the active ingredient in Ozempic (for type 2 diabetes), Wegovy (for weight management), Wegovy Pill (the oral version of semaglutide approved in 2025), and Rybelsus (Wegovy Prescribing Information). It is a GLP-1 receptor agonist, which is the medical term for medications that activate a receptor in your body that helps regulate blood sugar and appetite (StatPearls).
Tirzepatide is the active ingredient in Mounjaro (for type 2 diabetes) and Zepbound (for weight management). It is a dual GIP and GLP-1 receptor agonist, which means it activates two related receptors instead of one (Mounjaro Prescribing Information). In head-to-head clinical trials in adults with obesity, tirzepatide produced more weight loss on average than semaglutide, though side effect profiles and individual response vary.
Both work in similar ways at a high level. They slow how fast your stomach empties, they signal fullness to your brain, and they reduce appetite. They are different molecules with different dosing and different price points, and your clinician will weigh which one is the better fit for your medical history and your insurance situation. We have a direct comparison of tirzepatide and semaglutide if you want to dig into the trade-offs in more detail, and a primer on what makes these specific medications different from other peptides being discussed online.
3. Titration Is the Slow Climb to Your Real Dose
When people first hear about GLP-1 medications, they often picture starting at the full dose right away. That is not how it works.
Titration means you start at a low dose and step up slowly over the course of months. Wegovy, for example, begins at 0.25 mg once a week for four weeks, then 0.5 mg for four weeks, then 1 mg for four weeks, then 1.7 mg for four weeks, before reaching the maintenance dose of 2.4 mg (Wegovy Prescribing Information). The full titration usually takes 16 to 20 weeks. Tirzepatide has its own titration schedule with a similar pattern of small monthly steps (Mounjaro Prescribing Information).
The slow climb is not about being cautious for no reason. It is about giving your stomach and digestive system time to adjust to how the medication slows gastric emptying (Wegovy Prescribing Information). People who titrate gradually tend to have fewer side effects like nausea and constipation than those who try to move up faster, which is why we have a full guide to common GLP-1 side effects and when they happen so you know what is normal at each step. Some patients hold a lower dose longer if they are getting good results without going higher, or if they need more time at one step before moving up.
For your first conversation, the practical thing to know is that you are signing up for a months-long process, and the version of you that hits the maintenance dose in the spring is going to be on a different dose than the version of you starting in January. That is normal.
4. Food Noise Is a Real Thing
One of the most common things people say after starting a GLP-1 medication is that the constant background chatter about food in their head got quieter. Researchers now have a name for it: food noise.
Food noise is the persistent, intrusive thoughts about food that some people experience throughout the day, often distinct from physical hunger. It can feel like a running commentary about what to eat next, what is in the kitchen, whether to stop at the drive-through, or whether you should be eating right now even though you are full (Nature Nutrition & Diabetes). For people who have it strongly, it is exhausting. For people who do not, it can be hard to imagine.
The idea has become widely discussed only in the last few years, in large part because GLP-1 medications quiet it for many people, and patients started reporting the absence of something they had been living with for years without naming it (FoodNavigator). If this is hitting close to home as you read it, you are not alone, and it is worth bringing up at your appointment. We have a longer read on what food noise actually is if you want the full picture before you go in.
5. Compounded Versus Brand-Name GLP-1s
This is the part that confuses most people walking into a first conversation, especially after seeing wildly different prices online.
Brand-name GLP-1 medications are FDA-approved finished drugs made by a pharmaceutical manufacturer. Wegovy, Ozempic, Mounjaro, and Zepbound are all in this group. Their dosing, manufacturing standards, and labeling are reviewed by the FDA, and they are dispensed through traditional pharmacies.
Compounded GLP-1 products are made by licensed compounding pharmacies for patient-specific reasons, often when there is a shortage or when a patient needs a customized formulation. They are not FDA-approved as finished drugs (FDA). The legitimate compounded GLP-1 products in the market come from 503A or 503B compounding pharmacies, which operate under specific federal and state rules.
Compounded GLP-1 products are not the same thing as supplements or grey market peptides bought online. A compounded GLP-1 from a licensed pharmacy is a real medication produced under a real legal framework. The questions worth asking are about who is making it, what their licensing is, and how the price is structured. If you see a compounded GLP-1 advertised at a fraction of the brand-name price, that is not by itself a red flag. The flag is whether the seller is a licensed compounding pharmacy with a real prescriber behind it.
How to Walk Into the Conversation
A few questions worth bringing with you, written down or in your phone:
- Do I qualify based on my BMI or my other health conditions?
- Which medication do you recommend for me, and why that one?
- What does my titration schedule look like, and how long until I am at the maintenance dose?
- What are the most common side effects, and how do I manage them?
- Is the prescription going to be a brand-name medication or a compounded version, and which pharmacy will fill it?
- What does this cost per month, and is there a cheaper option that is still safe and licensed?
If you do not already have a clinician for this conversation, the GLP Winner provider survey helps you compare telehealth options that publish clinician names, pharmacy details, and pricing up front. The insights hub has additional plain-language reads on side effects, costs, and what to watch for in any provider.
Final Takeaway
A first GLP-1 conversation is not a final decision. It is an information-gathering meeting where you and a clinician figure out whether one of these medications fits your situation and which one makes sense if it does. The five things in this article are the basics most people are missing when they walk in.
You do not have to memorize anything before you go. Knowing that titration is slow, that semaglutide and tirzepatide are the two main ingredients, that food noise is a real and named experience, and that compounded products are a separate but legitimate category from brand-name medications, will get you most of the way there. The rest is what your clinician is for.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Sources
Keep Reading

Learn what to expect before starting a GLP-1 — supplies, mindset, telehealth basics, safety tips, and how to prepare for your first dose.

Thinking about starting a GLP-1? Here’s how to prepare, what to ask, and what to do if your doctor says no — without guilt or confusion.

Learn 6 simple steps to ask your doctor for a GLP-1 prescription and talk confidently about safe, effective weight-loss options.

Learn the real differences between tirzepatide and semaglutide, how each works, typical side effects, and what to ask your provider before starting.
